A 7-year-old girl with newly diagnosed childhood absence epilepsy has experienced multiple staring spells daily, confirmed on EEG with 3-Hz spike-and-wave discharges. Her parents are concerned about medication side effects. Which of the following is the most appropriate initial monotherapy, balancing efficacy and toxicity?